BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hakeem AR, Papoulas M, Menon KV. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer – A systematic review. European Journal of Surgical Oncology 2019;45:83-91. [DOI: 10.1016/j.ejso.2018.08.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Low SK, Giannis D, Thuong ND, Nam NH, Alshareef A, Koulas I, Geropoulos G, Moris D, Molmenti EP, Huy NT. Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 2015. Am J Clin Oncol 2022;45:306-15. [PMID: 35700074 DOI: 10.1097/COC.0000000000000918] [Reference Citation Analysis]
2 Casabianca AS, Tsagkalidis V, Burchard PR, Chacon A, Melucci A, Reitz A, Swift DA, McCook AA, Switchenko JM, Shah MM, Carpizo DR. Surgery in combination with systemic chemotherapy is associated with improved survival in stage IV gallbladder cancer. Eur J Surg Oncol 2022:S0748-7983(22)00534-0. [PMID: 35773092 DOI: 10.1016/j.ejso.2022.06.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cotter G, Beal EW, Poultsides GA, Idrees K, Fields RC, Weber SM, Scoggins CR, Shen P, Wolfgang C, Maithel SK, Pawlik TM. Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: a multi-institutional analysis. HPB 2022. [DOI: 10.1016/j.hpb.2022.06.008] [Reference Citation Analysis]
4 Zhang B, Li S, Liu ZY, Peiris KGK, Song LF, Liu MC, Luo P, Shang D, Bi W. Successful multimodality treatment of metastatic gallbladder cancer: A case report and review of literature. World J Clin Cases 2022; 10(12): 3856-3865 [DOI: 10.12998/wjcc.v10.i12.3856] [Reference Citation Analysis]
5 Berger Y, Sullivan BJ, Leigh NL, Bekhor EY, Dhorajiya P, Mani M, Magge DR, Cha DE, Sarpel U, Hiotis SP, Labow DM, Ward SC, Golas BJ, Cohen NA. Gallbladder Cancer: A Single-Institution 10-Year Experience-Analysis of Adenocarcinoma Subtypes and Tumors Arising from Intracholecystic Papillary Neoplasms. Ann Surg Oncol 2022. [PMID: 35437668 DOI: 10.1245/s10434-022-11719-6] [Reference Citation Analysis]
6 Takahashi H, Irri A, Fenig Y, Byale A, Thung S, Gunasekaran G. Systematic review of squamous cell carcinoma of the gallbladder. The American Journal of Surgery 2022. [DOI: 10.1016/j.amjsurg.2022.04.024] [Reference Citation Analysis]
7 Ozer M, Goksu SY, Sanford NN, Porembka M, Khurshid H, Ahn C, Maxwell MC, Beg MS, Kazmi SM. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer. JAMA Netw Open 2022;5:e2146912. [PMID: 35171262 DOI: 10.1001/jamanetworkopen.2021.46912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Inoue M, Hakoda K, Sawada H, Hotta R, Ohmori I, Miyamoto K, Toyota K, Sadamoto S, Takahashi T. Locally advanced gallbladder cancer treated with effective chemotherapy and subsequent curative resection: a case report. J Med Case Rep 2022;16:30. [PMID: 35039070 DOI: 10.1186/s13256-021-03248-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Goel S, Aggarwal A, Iqbal A, Talwar V, Mitra S, Singh S. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India. World J Gastroenterol 2021; 27(45): 7813-7830 [PMID: 34963744 DOI: 10.3748/wjg.v27.i45.7813] [Reference Citation Analysis]
10 Okumura K, Gogna S, Gachabayov M, Felsenreich DM, McGuirk M, Rojas A, Quintero L, Seshadri R, Gu K, Dong XD. Gallbladder cancer: Historical treatment and new management options. World J Gastrointest Oncol 2021; 13(10): 1317-1335 [PMID: 34721769 DOI: 10.4251/wjgo.v13.i10.1317] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
11 Takada N, Sugano H, Shirai Y, Saito N, Hamura R, Taniai T, Uwagawa T, Yanaga K, Ikegami T, Ohashi T, Eto K. Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells. PLoS One 2021;16:e0257019. [PMID: 34473771 DOI: 10.1371/journal.pone.0257019] [Reference Citation Analysis]
12 Littau MJ, Kulshrestha S, Bunn C, Kim P, Luchette FA, Baker MS. Is positive histologic surgical margin associated with overall survival in patients with resectable gallbladder cancer? Surg Open Sci 2021;6:15-20. [PMID: 34409279 DOI: 10.1016/j.sopen.2021.07.003] [Reference Citation Analysis]
13 Koppatz H, Takala S, Peltola K, But A, Mäkisalo H, Nordin A, Sallinen V. Gallbladder cancer epidemiology, treatment and survival in Southern Finland - a population-based study. Scand J Gastroenterol 2021;56:929-39. [PMID: 34224306 DOI: 10.1080/00365521.2021.1915373] [Reference Citation Analysis]
14 James M, Kalayarasan R, Gnanasekaran S, Pottakkat B. Laparoscopic hepatopancreatoduodenectomy for locally advanced gall bladder cancer. J Minim Access Surg 2021;17:369-72. [PMID: 33605929 DOI: 10.4103/jmas.JMAS_179_20] [Reference Citation Analysis]
15 Giannis D, Cerullo M, Moris D, Shah KN, Herbert G, Zani S, Blazer DG 3rd, Allen PJ, Lidsky ME. Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors. Cancers (Basel) 2021;13:547. [PMID: 33535552 DOI: 10.3390/cancers13030547] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
16 Matsuyama R, Yabusita Y, Homma Y, Kumamoto T, Endo I. Essential updates 2019/2020: Surgical treatment of gallbladder cancer. Ann Gastroenterol Surg 2021;5:152-61. [PMID: 33860135 DOI: 10.1002/ags3.12434] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Yang Y, Tu Z, Ye C, Cai H, Yang S, Chen X, Tu J. Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study. BMC Surg 2021;21:59. [PMID: 33485332 DOI: 10.1186/s12893-021-01068-8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Belkouz A, Nooijen LE, Riady H, Franken LC, van Oijen MGH, Punt CJA, Erdmann JI, Klümpen HJ. Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review. Cancer Treat Rev 2020;91:102110. [PMID: 33075684 DOI: 10.1016/j.ctrv.2020.102110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Kuipers H, de Savornin Lohman EAJ, van Dooren M, Braat AE, Daams F, van Dam R, Erdmann JI, Hagendoorn J, Hoogwater FJH, Groot Koerkamp B, van Gulik TM, de Reuver PR, de Boer MT. Extended Resections for Advanced Gallbladder Cancer: Results from a Nationwide Cohort Study. Ann Surg Oncol 2021;28:835-43. [PMID: 32696306 DOI: 10.1245/s10434-020-08858-z] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Kingham TP, Aveson VG, Wei AC, Castellanos JA, Allen PJ, Nussbaum DP, Hu Y, D'Angelica MI. Surgical management of biliary malignancy. Curr Probl Surg 2021;58:100854. [PMID: 33531120 DOI: 10.1016/j.cpsurg.2020.100854] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Gamboa AC, Maithel SK. The Landmark Series: Gallbladder Cancer. Ann Surg Oncol 2020;27:2846-58. [PMID: 32474816 DOI: 10.1245/s10434-020-08654-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
22 Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. J Surg Oncol 2020;122:176-82. [PMID: 32383268 DOI: 10.1002/jso.25907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Patkar S, Chaturvedi A, Goel M, Rangarajan V, Sharma A, Engineer R. Role of positron emission tomography-contrast enhanced computed tomography in locally advanced gallbladder cancer. J Hepatobiliary Pancreat Sci 2020;27:164-70. [PMID: 31945262 DOI: 10.1002/jhbp.712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
24 Su W, Jiang X, Chen M, Huang M, Tang N, Wang X, Li X, She F, Chen Y. cIAP1 promotes proliferation and migration and prevents apoptosis in gallbladder cancer in vitro. Biosci Rep 2019;39:BSR20182266. [PMID: 30902881 DOI: 10.1042/BSR20182266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]